Received May 27, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 343DD | — |
expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) solution for injection (batch number 343DD with expiry date 30-APR-2026) for prophylaxis. On 21-MAY-2026, the patient received Menveo. On 21-MAY-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 21-MAY-2026 The patient received Menveo (1 vial). The reporter asked whether the vaccine would still be effective and there would be any possible adverse event for this patient.